The emergence of antibiotic-resistant bacteria poses a significant challenge to public health worldwide. Vancomycin, a potent antibiotic, is often used as a last resort for treating infections caused by such bacteria. However, the monitoring of vancomycin levels in patients' blood is crucial to ensure its therapeutic efficacy and prevent toxicity. In this article, we delve into the development and application of a one-step lateral flow immunoassay for the rapid and efficient detection of vancomycin in whole blood samples. We discuss the principles behind the assay, its advantages over traditional methods, and its potential implications for clinical practice.
HTML PDFShare this article
Journal of Bioengineering & Biomedical Science received 307 citations as per Google Scholar report
